Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly-Reference-Cited by-同舟云学术

Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly

Published:2020-11 Issue: Volume:25 Page:67-74
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Yamazaki Hideya,Masui Koji,Suzuki Gen,Shimizu Daisuke,Aibe Norihiro,Yamada Kei,Fujihara Atsuko,Shiraishi Takumi,Okihara Koji,Ukimura Osamu,Yoshida Ken,Nakamura Satoaki,Okabe Haruumi

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference22 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®); Prostate Cancer 2016 Version 4; National Comprehensive Cancer Network: Fort Washington, PA, USA, 2016.

3. Management of prostate cancer in elderly patients: recommendations of a task force of the international society of geriatric oncology;Droz;Eur Urol,2017

4. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer;Hamdy;N Engl J Med,2016

5. Fifteen-year outcomes following conservative management among men aged 65 years or older with localized prostate cancer;Lu-Yao;Eur Urol,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronological Changes of Lower Urinary Tract Symptoms in Elderly Patients with Prostate Cancer after Low-Dose-Rate Prostate Brachytherapy;Life;2023-07-04

2. Management of Localized Prostate Cancer in Elderly Patients;The Bulletin of Urooncology;2022-09-05

3. Irradiation of localized prostate cancer in the elderly: A systematic literature review;Clinical and Translational Radiation Oncology;2022-07

4. High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort;Clinical and Translational Radiation Oncology;2022-07